← Browse by Condition
Medical Condition

neurologic disorders

Total Trials
3
Recruiting Now
3
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for neurologic disorders sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — neurologic disorders Clinical Trials

How many clinical trials are currently recruiting for neurologic disorders?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for neurologic disorders, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for neurologic disorders?
neurologic disorders research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a neurologic disorders clinical trial?
Eligibility criteria for neurologic disorders trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
National Institute of Neurological Disorders and Stroke (NINDS) 1 trial
MD Stem Cells 1 trial
Baylor University 1 trial

Recruiting Clinical Trials

NCT00060541
Recruiting
Evaluation and Treatment of Neurosurgical Disorders
Enrollment
5,000 pts
Location
United States
Sponsor
National Institute of Neurolog...
View Trial →
NCT02795052
Recruiting
Neurologic Stem Cell Treatment Study
Enrollment
500 pts
Location
United States, Unite...
Sponsor
MD Stem Cells
View Trial →
NCT07280923
Recruiting
Reliability and Validity of the PReFS
Enrollment
15 pts
Location
United States
Sponsor
Baylor University
View Trial →

Related Conditions

stroke (2) traumatic brain injury (2) nervous system diseases (1) neurodegenerative diseases (1) neurological disorders (1) cadasil (1) chronic traumatic encephalopathy (1) cerebral infarction (1) cerebral ischemia (1) cerebral stroke (1) cerebral hemorrhage (1) parkinson (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology